CANCELLED – COURSE WILL BE RESCHEDULED FOR FALL 2020

The Science of Whitening and Make the Recommendation: Toothpaste as Treatment

Date:               March 28, 2020 – Saturday

Time:               8:30am – 11:30am

Location:         5850 E. Still Circle, Saguaro Rm.

Audience:        All Dental Professionals

Format:           Lecture

CE Credit:       2.5 credits

Tuition:           $65

TWO COURSES, ONE HALF DAY!

The Science of Whitening

In the first of this 2-part course, we will discuss a predictable, efficient, and state-of-the-art whitening system that uses advanced ionic technology to transform the whitening experience for both dental practitioner and patient. We will look at the differences between whitening and bleaching products and explore strategies for patient discussion regarding whitening procedures and managing treatment expectations.

Learning Objectives:
•       Explain how tooth-whitening technology works.
•       Describe indications for home and professional tooth whitening options.
•       Effective conversation to discuss tooth whitening and expectations with patients.
•       Make clinical decisions about patient selection for successful tooth whitening.
•       Develop effective tooth whitening messages and marketing strategies.

 Make the Recommendation: Toothpaste as Treatment

In this session, we will explore the formulation and action of toothpastes. Discussion regarding both active and inactive ingredients will enable the dental professional to understand how and why each product works and how they differ from one another. Therapeutic benefits, mechanisms of action, and assist the dental professional with assessing the needs of today’s complex patients and providing them with an appropriate toothpaste recommendation.

Learning Objectives:

• Explain the principle therapeutic outcomes of various toothpaste formulations.
• Describe how fluoride is assimilated into the apatite crystal of enamel.
• Discuss reduction of biofilm and gingivitis via toothpaste.
• Describe management of dentin hypersensitivity with potassium nitrate.
• Determine the appropriate dentifrice based upon individual patient need.

 Meet the Presenter:

Linda D’Amico, RDH, BS has been in the dental profession for 25+ years, first as a clinical dental hygienist and then as a sales representative. She has spent the past 10 years as an Oral Care Consultant with Colgate and enjoys sharing what she has learned with other dental professionals. Linda has provided continuing education to a wide variety of audiences including dental and allied dental students, dental study groups, and organize dentistry groups.

Register below under “Choose Tuition Type”

DAY OF COURSE DETAILS AVAILABLE HERE

This course is sponsored in part by an unrestricted educational grant from Colgate.

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Arizona School of Dentistry & Oral Health and Colgate.

Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Arizona School of Dentistry & Oral Health designates this activity for 2.5 continuing education credits.

Primary Care Update

Mar. 5-7, 2020

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

This course is designed to improve the knowledge and understanding of medicolegal aspects of concussion.  Athletic trainers in all settings who work with athletes suffering from concussions should have a thorough understanding of the medicolegal aspects of these cases.  Understanding the current landscape of concussion legislation, knowing how to analyze best practice guidelines, and how to incorporate concussion management protocols into practice are proactive ways the practicing athletic trainer can work to mitigate the risk of litigation.  This presentation will cover these topics with the following objectives:

The specific objectives for this course include the development of the participant’s ability to:

1. Describe the current landscape of concussion legislation
2. Discuss basic legal terminology
3. Analyze the importance of best practice guidelines in concussion management to prevent potential litigation
4. Incorporate current concussion management protocols into medical practice to prevent potential litigation
5. Review current litigation trends

According to the education levels described by the PDC, this continuing education course is considered to be Essential Level, and is appropriate for all athletic trainers.

(1.25 Category A CEUs – FREE)

ASDOH Alumni Weekend – Clinical Updates 2020

Saturday, February 29, 2020

8:00am – Noon   4 CEU

A.T. Still University, 5850 E. Still Circle

Tuition: General – $65, ASDOH Faculty and Alumni – No Charge

Continental Breakfast and Networking begin at 7:30 a.m.

This 3-part course includes:

CBCT: The Critical Third Dimension – How This Imaging Modality can Impact your Diagnosis and Subsequent Treatment

Presented by: R. Todd Erickson, DDS, MS

In this session we will explore a variety of patient cases as you learn how the choice and interpretation of radiologic images can assist with differential diagnosis and recommended treatment.

At the conclusion of this presentation, attendees will be able to:

1.       Explain the benefits and shortcomings of various imaging modalities.

2.       Select the appropriate imaging modality for a specific purpose.

3.       Describe pathology frequently found in the oral and maxillofacial region.

4.       Determine when to treat, follow, or refer a patient.

The Latest and Greatest in Digital Dentistry

Presented by: Carlos Jurado, DDS, MS

Digital dentistry has been evolving rapidly over the last 10 years with restorative techniques in the forefront of the field. Novel technologies have been used in both the clinic and laboratory with a goal of manufacturing restorations quickly, easily, and more accurately. In addition, patients are more attracted to the digital workflow than conventional techniques. This lecture will present novel techniques for the fabrication of removable complete and partial prostheses, chair-side CAD/CAM fixed provisional and final restorations, printed diagnostic models and wax-ups, and more.

At the conclusion of this presentation, attendees will be able to:

1.       Evaluate the incorporation of digital technology in modern dentistry.

2.       Describe the laboratory and clinical workflow of different scenarios.

3.       Identify indications for and limitations of digitally designed and fabricated prostheses

An Overview of Common Oral Lesions: Diagnosis and Management

Presented by: Seena Patel, DMD, MPH

Dentists are first-line providers for patients with oral lesions. Appropriately diagnosing and managing oral mucosal diseases can be challenging, and patients often see several providers before obtaining a correct diagnosis. A sound understanding of oral mucosal diseases and following a systematic approach to diagnosis can help prevent unnecessary office visits, diagnostic tests, treatments, and most importantly, a delayed diagnosis. This presentation will outline common conditions affecting the oral soft tissues and how to manage them. It will aid clinicians in forming differential diagnoses and in understanding how to order appropriate diagnostic tests. Further, it will highlight the importance of a comprehensive oral health examination.

At the conclusion of this presentation, attendees will be able to:

1.       Formulate a differential diagnosis for common oral lesions.

2.       Define the etiology for various oral lesions.

3.       Describe management strategies for common oral lesions.

4.       Differentiate between benign and malignant oral lesions.

5.       Implement a strategy for when to refer suspicious oral lesions.

Meet the Instructors

Todd Erickson, DDS, MS, Associate Professor of Radiology at ASDOH, is a graduate of Creighton University School of Dentistry. Dr. Erickson received a certificate in Oral and Maxillofacial Surgery from Detroit-Malcomb Hospital Corp. and worked in private practice for more than a decade before earning a Master of Science in Oral and Maxillofacial Radiology from the University of North Carolina.

Carlos Jurado, DDS, MS, is Director of Clinical Digital Dentistry at Arizona School of Dentistry & Oral Health. Dr. Jurado earned a Certificate in Restorative Dentistry from UCLA and a Certificate in Operative Dentistry from USC. He earned his MS in Dental Materials and Certificate in Prosthodontics at the University of Alabama at Birmingham. Dr. Jurado was Co-Director of CAD/CAM Dentistry at Oregon Health and Science University School of Dentistry prior to joining ASDOH. He has lectured nationally and internationally and published extensively on dental materials and restorative topics.

Dr. Seena Patel obtained her DMD and MPH degrees from A.T. Still University Arizona School of Dentistry & Oral Health (Class of 2010) and completed a residency in Orofacial Pain and Oral Medicine at USC. Dr. Patel is an Associate Professor and Associate Director of Oral Medicine in the Advanced Care Clinic at ASDOH and also in private practice. She is a Diplomate of the American Board of Orofacial Pain and the American Board of Oral Medicine, and a member of the American Academy of Orofacial Pain, American Academy of Oral Medicine, Central Arizona Dental Society, Arizona Dental Association, American Dental Association, American Dental Education Association, and Special Care in Dentistry Association.

Register below under “Choose Tuition Type”

Day of Course information available here.

A.T. Still University Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. A.T. Still University Arizona School of Dentistry & Oral Health designates this activity for 4 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP

PROGRAM DESCRIPTION

February 21-23, 2020

This 3-day (25.5 hour) course is primarily geared towards the clinician interested in learning evidence-based management for both the vestibular and/or concussion (m-TBI) patient. The workshop will present both assessment and rehabilitation protocols to manage identifiable vestibular and balance system disorders, including cortical and labyrinthine concussion. Evidence based protocols will be presented, demonstrated, and practiced to ensure clinicians produce excellent outcomes. The workshop will include significant hands-on practice to increase skill competencies.

For more information and to register, please visit: https://www.dizzy.com/market/?product_cat=&workshop-location=1040

A.T. Still University Arizona School of Dentistry & Oral Health Still Research Institute and the

Arizona Section of the American Association for Dental Research

4th Annual Scientific Symposium

 Date:  February 15, 2020 – Saturday

Time:  8:00am – 2:00pm

Location:  ATSU Campus 5850 E. Still Circle

CE Credit:  5 credits

Tuition: $100 / Students $25 (Faculty discount available)

Join an interdisciplinary audience of dental and dental hygiene clinicians, academicians and researchers, dental and dental hygiene students, nurses, physicians and scientific and industry partners from Arizona and the surrounding region as we learn about Arizona’s oral healthcare and research communities. The goals for this Symposium include:

1. Share new knowledge obtained through original research
2. Translate current findings from research to support best practices
3. Increase and diversify the number of individuals engaged in oral health research
4. Cultivate collaborative partnerships to improve the oral health of the community

Speakers and Topics

• Advances in Precision Medicine presented by Maria E. Ryan, DDS, PhD, Immediate Past President of AADR and Chief Scientific Officer, Colgate-Palmolive Company
• Understanding and Managing Periodontal Disease: An Impressive Century of Progress presented by Ray Williams, DMD, Adjunct Professor of Periodontology, University of North Carolina – Chapel Hill
• HPV-Associated Cancers: The Dentist’s Role in Vaccination presented by Alexis Koskan, PhD, Assistant Professor of Public Health, Arizona State University and Seena Patel, DMD, MPH, Associate Director of Oral Medicine and Associate Professor, ASDOH ATSU
• Student Research Poster Competition

Register below under “Choose Tuition Type”

Full course details and day of event information available here

Questions? Contact aspolarich@atsu.edu

This symposium is sponsored in part by an unrestricted educational grant from Colgate.

Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP

SOLD OUT THIS YEAR

Instructor: Christopher Powers, PT, PhD, FACSM, FAPTA

Overview/Objectives of Course:

Altered kinematics can underlie various musculoskeletal conditions including hip and low back pain. Understanding how abnormal movement patterns can contribute to pathomechanics of the hip and lumbar spine is essential for physical therapist practice. This lab-based course will review the mechanics of the hip and spine in relation to various clinical diagnoses. Evaluation of abnormal hip and spine mechanics and prescription of exercise interventions will be addressed.

Course Objectives/Learning Outcomes:
At the conclusion of the course the participant will be able to:

1. Describe the biomechanical coupling between the hip, pelvis & lumbar spine
2. Describe common movement impairments that may contribute to low back pain.
3. Describe common movement impairments that may contribute to hip pain & pathology.
4. Plan appropriate treatment interventions to correct movement impairments related to hip and low back pain.

Course Schedule:

8:00-8:30 Overview: The hip/spine connection

8:30-10:00 Movement impairments & hip pain & pathology

10:00-10:15 Break

10:15-11:00 Movement impairments related to low back pain

11:00-12:00 Exercise interventions for hip and low back pain

12:00-1:00 Lunch

1:00-2:45 Movement evaluation lab

2:45-3:00 Break

3:00-5:00 Exercise intervention lab

CEU’s Awarded: 0.8 or 8 Contact Hours

Primary Care Update

Jan. 12-19, 2020

Click MORE for program information and tuition pricing.

ROYAL CARIBBEAN – Allure of the Seas
7-night | Western Caribbean
Cruise Departure: Fort Lauderdale, Florida
Ports: Perfect Day at CocoCay, Bahamas | Nassau, Bahamas | Cozumel, Mexico | Costa Maya, Mexico

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Primary Care Update: Challenges of Care

Dec. 5-7, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

THANK YOU to our Program Supporters

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Dermatology Hands-on Workshop

Dec. 5, 2019 | 8:00 a.m. – 11:00 a.m.

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Sponsored by the Orthopedic and Neurologic Physical Therapy Residency programs at A.T. Still University in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences. The Orthopedic and Neurologic Physical Therapy Residency programs are accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Lori Bordenave, PT, DPT, PhD and Tawna Wilkinson, PT, DPT, PhD

Course Times:

Friday 11/15: 12pm – 5pm

Saturday 11/16: 8am – 5pm

Sunday 11/17: 8am – 12pm

Course Description: This program is designed primarily for people interested in or involved with clinical education (clinical instructors [CIs], Site Coordinator of Clinical Education [SCCEs], Director of Clinical Education [DCEs]) and is recognized by APTA as a Clinical Instructor (CI) Education and Credentialing Program.

Course Objectives:
1. Preparing for physical therapy students during their clinical education experiences

2. Developing learning experiences

3. Supporting ongoing learning through questioning and effective feedback

4. Developing skills of performance evaluation

5. Identifying and managing students with exceptional situations

6. Identifying legal implications for clinical educators, including issues presented by ADA legislation

CEU: Participants are awarded 1.5 CEUs or 15 contact hours at the end of the course.

FIRM REGISTRATION DEADLINE: October 18, 2019

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program

Laser: An Emerging Scientific Technology Workshop

Date:             November 2, 2019 – Saturday

Time:            8:00am – 4:30pm – 1 hr lunch break on your own

Location:     5850 E. Still Circle, Cougar classroom, 3rd Fl.

Audience:    Dentist, Dental Hygienist

Format:        Lecture, Hands-On

CE Credit:    7 credits

Tuition:        $385

Course Description:

Laser is changing the way dentistry is viewed and practiced. Join us as we explore the value of laser assisted hygiene and its relationship to tissue healing as well as discuss the patient’s perception and expectations of lasers. In this comprehensive, hands-on clinical workshop participants will learn the adjunctive use of laser as a component of periodontal therapy and as a tool for risk management. Working with simulation exercises, detailed instrumentation photography and video, this course will allow practitioners to build clinical skills, confidence, and an understanding of periodontal treatment protocols using soft tissue dental lasers.

Learning Objectives:

• Discuss the science of laser wavelengths and their absorption characteristics.
• Discuss the adjunctive use of laser in periodontal therapy and recall risk management.
• Apply clinical techniques and methods associated with laser disinfection and laser sulcular debridement.
• Identify the variables of laser energy protocols as they apply to the treatment of gingivitis, chronic, and aggressive periodontitis.
• Interpret tissue interaction when exposed to “warm” and “hot” laser settings and describe techniques to obtain optimum clinical results.
• Describe the specifics of initiated and bare fiber tip applications.
• Determine clinical decisions and laser treatment protocols.

This course includes lecture and hands-on components and is in compliance with Arizona Administrative Code R4-11-601-H. Licensed participants will be eligible to use soft tissue lasers in Arizona clinical practice upon course completion.

Meet the Instructor:

Janet Press, RDH has practiced in general and periodontal dentistry since 1975. Ms. Press received her soft tissue laser training through the Academy of Laser Dentistry (ALD) and holds an ALD Fellowship. As a faculty member at the Las Vegas Institute for Advanced Dental Studies, Janet was Co-Director of the Dynamic Team and Laser Certification programs. Internationally recognized as an expert in the field of dental hygiene laser education, she provides laser training in the academic environment as well as the private sector. Janet has been named a “Distinguished Dental Professional” by Dentsply International, is a member of the American Dental Hygienists’ Association, the American Academy of Oral Systemic Health, the Academy of Laser Dentistry, and is the owner of 21st Century Dentistry, LLC specializing in dental team communication and clinical education. Ms. Press has not declared any conflicts of interest related to this course.

FULL COURSE AND DAY OF EVENT DETAILS AVAILABLE HERE

Register early – seats are limited!

A.T. Still University Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. A.T. Still University Arizona School of Dentistry & Oral Health designates this activity for 3 continuing education credits.

Description:
This course presents essential evidence-based tests and measures used for
examination of neurologic impairments, activity limitations, and
participation restrictions with application to case studies. The focus of the
course is practicing and applying these outcome measures organized
according to International Classification of Functioning, Disability and Health
(ICF) levels.

Objectives:
At completion of this course, the participant will be able to:
• Discuss the choice of outcome measures based on the ICF model,
psychometric properties, and recomendations from the StrokEDGE, TBI EDGE,
and Core Measures CPG of the Academy of Neurologic Physical Therapy
• Demonstrate tests and measures of impairment, activity limitations and
participation measures for individuals with stroke and traumatic brain injury
• Make recommendations for tests and measures for individuals with stroke
and brain injury

Course Instructors: 

Cecelia Glittenberg, PT, PhD; Virginia Little, PT, PhD; Tracy Ellison, PT, DPT

11-12.25 Contact hours earned at course completion

*Course limited to 24 participants

Course Flyer & Schedule

Complementary and Alternative Local Anesthesia: Beyond the Basic Techniques

Date:                 October 19, 2019 – Saturday

Time:                8:30am – 11:30am

Location:        5850 E. Still Circle, Saguaro Rm.

Audience:       Dentist, Dental Hygienist

Format:           Lecture

CE Credit:      3 credits

Tuition:          $65

Course Description:

This course will expand your local anesthesia knowledge by providing an evidence-based perspective on anatomy, technique, technology, pharmacology, and human factors that contribute to positive pain control outcomes. Alternatives to common injection techniques based on anatomical advantage will be discussed and include the “short needle IA”, “high IA block”, “retromolar” delivery techniques, and supplemental infiltrations. Complementary techniques and concepts for ergonomic benefit and patient management will be covered including CCLAD delivery methods, buffering systems, eutectic topical anesthetic preparations and distraction devices. Key points for use and administration of a new nasal delivered topical anesthetic will also be presented.

Learning Objectives:
At the conclusion of this course, participants will be able to:

• Use patient anatomical evidence to modify common injection techniques.
• Describe how buffering systems work and can be implemented into practice.
• Discuss the impact of the manual syringe on work-related musculoskeletal injuries and the advantages of CCLAD techniques.
• Incorporate distraction devices to minimize patient pre-injection stress and discomfort.
• Recognize indications for and describe techniques of nasal delivery local anesthesia.

Meet the Presenter: 

Kathy Bassett RDH, MEd, has over 40 years of experience as an expanded functions dental hygienist in general and specialty dental environments, and 30 years as a professor of dental hygiene and adjunct professor of dentistry. She is a co-author of the textbook Local Anesthesia for Dental Professionals, has authored numerous articles and textbook chapters on local anesthesia, and has presented hundreds of CE courses locally, nationally, and internationally. Ms. Bassett has not declared any conflicts of interest related to this course.

Full course details and day of event information available HERE

A.T. Still University Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. A.T. Still University Arizona School of Dentistry & Oral Health designates this activity for 3 continuing education credits.

Osteopathic Approach to Primary Care: Integrating OMM into the Management of Common Conditions

Oct. 10-12, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

The New Classification of Periodontal and Peri-Implant Diseases and Conditions

Date:             September 28, 2019 – Saturday

Time:            8:30am – 11:30am

Location:      5850 E. Still Circle, Saguaro Rm.

Audience:     Dentist, Dental Hygienist, Dental Assistant

Format:        Lecture

CE Credit:   3 credits

Tuition:        $65

Course Description:

This course will provide an overview of the major highlights from the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. We will discuss the rationale for the updated system and compare and contrast it to previous guidelines. Through use of case studies and clinical examples, participants will also learn to interpret and apply the new classification system.

Learning Objectives:

At the conclusion of this presentation, participants will be able to:

1. Identify the key changes in classification introduced in the 2017 guidelines and compare them with the 1999 version.
2. Discuss the new terminologies introduced in the 2017 classification.
3. Interpret the multi-dimensional staging and grading system for periodontitis classification.

Meet the Speaker:

Satish Kumar, DMD, MDSc, MS, is Associate Professor of Periodontics at A.T. Still University Arizona School of Dentistry & Oral Health. Dr. Kumar’s background includes advanced specialty training in periodontology and dental implantology, oral medicine, temporomandibular disorders and orofacial pain, all at the University of Southern California. He is a Diplomate of the American Board of Periodontology, the American Board of Oral Medicine, and the American Board of Orofacial Pain. Dr. Kumar has published numerous articles, reviews, critical summaries and book chapters and serves as a peer reviewer for the Journal of Dental Research, Journal of Periodontology, and the Journal of the American Dental Association. Dr. Kumar has not declared any conflicts of interest related to this course.

REGISTER ONLINE NOW!

Full course details and day of event information available HERE.

A.T. Still University Arizona School of Dentistry & Oral Health is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. A.T. Still University Arizona School of Dentistry & Oral Health designates this activity for 3 continuing education credits.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Kathy Petkovsky, PT, CHT and Cheri Hodges, PT, DPT

Course Description: This course is a lecture and lab course intended for physical therapists working in a general orthopedic clinical practice. The primary instructor has over 30 years of clinical
practice as a CHT. The upper extremity conditions covered includes tendinopathies, peripheral nerve entrapments & fractures in the elbow, wrist, and hand regions.

Course Objectives:

At the conclusion of this course, participants will be able to:

1. Assess the elbow, wrist, and hand regions for common injuries and conditions.

2. Review current best evidence for examination and management of conditions in the region of the elbow, wrist, and hand.

3. Apply improved examination and intervention strategies.

4. Study preparation for the Orthopedic Clinical Specialty Exam (OCS)

CEU: Participants are awarded .7 CEUs or 7 contact hours at the end of the course.

Cost: $225; $175 for ATSU alumni and current Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

Upper Extremity course flyer

Internal Medicine Update for Primary Care Physicians

Aug. 2-4, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Colin Rigney, PT, DPT, OCS, RMSK 

Course Description

• This course will give clinicians knowledge on principles of musculoskeletal ultrasound, including general physics/machine instrumentation, anatomy, pathology and the current role for clinic application as it relates to Physical Therapists.
• This course is designed to give registrants maximal opportunity for practical learning with 4 hours of scanning in the afternoon. Due to the course being one day, the lecture topics will cover areas in the upper extremity most commonly seen in clinical practice

Course Objectives

• Give clinicians an understanding of ultrasound history
• Identify when musculoskeletal sonography is indicated to assist in managing and diagnosing common conditions
• Explain basic physics and instrumentation of ultrasound for optimal viewing potential
• Present information on common uses and limitations using MSK ultrasound
• Review of anatomy for upper extremity scanning
• Present most common pathology with MSK ultrasound
• Give clinicians understanding MSKUS utilization in current best practices
• Perform basic scans of the shoulder, elbow and hand/wrist

** The morning session will cover introduction to musculoskeletal ultrasound imaging and pathology as well as a live demonstration of selected anatomical sites. and introduction and afternoon session will consist of upper extremity scanning and practical application with our expert instructors

CEU: Participants are awarded 0.7 CEUs or 7 contact hours at the end of the course.

Cost: $175 APTA members;  $150 for non ATSU Alumni and Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

2019 ATSU Alaska CME/CE Cruise

Exploring Hot Topics in Primary Care

June 14-21, 2019

Click MORE for program information and tuition pricing.

ROYAL CARIBBEAN – OVATION OF THE SEAS | 7-night | Alaska Glacier Cruise
Cruise Departure: Seattle, Washington
Itinerary: Seattle, Washington | Alaska Inside Passage | Juneau, Alaska | Skagway, Alaska | Endicott Arm & Dawes Glacier |
                     Victoria, British Columbia | Seattle, Washington

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• • • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660.626.2232 for assistance.

Course Description:
The goal of this one-day course is to demystify the processes of physical therapy examination, evaluation and intervention in the comprehensive care of individuals with multiple sclerosis (MS). The course will cover the most current evidence and practice in the management of MS. The course will involve lecture, discussion, patient case study and live demonstration of strategies for implementation in the clinic.

Course Objectives:
At completion of this course, the participant will be able to:
• Describe the etiology, epidemiology, pathophysiology, signs and symptoms, diagnosis, and course of MS.
• Describe elements of the medical management of persons with MS (pwMS).
• Identify and describe the examination procedures used to inform the evaluation of pwMS to establish the physical therapy diagnosis, prognosis, and plan of care.
• Describe the role of the physical therapist in the management of pwMS in terms of direct interventions and patient/client-related instruction to maximize function and quality of life.
• Discuss common concerns of pwMS and identify community resources for this population.

Course Instructors:

Maria Rundell, PT, DPT
• Board Certified Specialist in Neurologic Physical Therapy
• Multiple Sclerosis Certified Specialist
• Lead Physical Therapist, Out-patient PT, Encompass Health Rehabilitation Hospital of Colorado Springs, CO

Thomas R. Holtackers PT (Ret)

Ryan Mueller, PT, DPT
• Physical Therapist, Out-patient PT, Encompass Health Rehabilitation Hospital of Colorado Springs, CO

Registration Fees: $195.00 or $160.00 for ATSU Alumni, Clincal Instructors with ATSU students, or groups of 3 or more from one organization.

Contact Hours: 7.5 Contact Hours or .75 CEU’s

Comprehensive Care in MS Course Flyer _ 2019

Date: April 8, 2019

Time: 5:30-7:30 pm

Location: 5850 E Still Circle Mesa, AZ 85206

Room: Cougar, 3rd Floor

Course description:

A discussion and demonstration will be provided on how the Otometrics Biologic AudX or AudX Pro otoacoustic emissions devices are utilized for pediatric and adult audiometric evaluation. Clinical considerations in use of otoacoustic emissions and types of otoacoustic emissions will be discussed. A step by step demonstration will also be provided. In addition, a discussion and demonstration of OAE assessment in the pediatric and adult population including considerations such as calibration, stimulus type and reporting results will be provided.

In addition, a discussion and demonstration will be provided on how various systems are utilized for evoked potentials such as ABR, ECochG and ASSR. The basics of evoked potentials will be reviewed along with a discussion of threshold assessment in both ABR and ASSR with hands-on practicum. The day will end with a review of frequently asked questions regarding all aspects of evoked potentials. The benefits of the use of evoked potentials to both the clinician and patient will be presented.

Patient database management will also be presented including integration with OTObase. OTObase is a tool utilized to integrate any NOAH compatible devices/applications into an Electronic Medical Record (EMR) system.

Learner outcome:

• Define anatomy related to generation of otoacoustic emissions
• Define types of otoacoustic emissions and their benefits: spontaneous, transient, distortion product OAEs
• Determine clinical applications of OAEs for different patient populations
• Determine troubleshooting strategies for improved OAE testing techniques
• Define unique features that improve testing efficiency with Biologic OAE testing equipment
• Demonstrate patient preparation and collection of auditory evoked potential data
• Troubleshoot and manipulate auditory evoked potential protocols as well as manage patient records

How to register:

Email: jason.faloon@natus.com or jeanette.fitzke@natus.com by April 1st, 2019.

CEU information:

Otometrics, a division of Natus, is approved by the American Academy of Audiology to offer Academy CEUs for this activity. The program is worth a maximum of 2  CEUs. Academy approval of this continuing education activity is based on course content only and does not imply endorsement of course content, specific products, or clinical procedure, or adherence of the event to the Academy’s Code of Ethics. Any views that are presented are those of the presenter/CE Provider and not necessarily of the American Academy of Audiology. This course is offered for up to .2 AAA CEUs.

Speaker Bio:

Jeanette Fitzke, AuD, joined Otometrics, division of Natus, in February 2015 as the West Regional Field Clinical Audiologist where she has trained several providers and given multiple local, state and national presentations and lectures on a variety of Audiology, Vestibular, Telehealth, and Business related topics pertinent to the hearing and balance healthcare industry. She has 17 years of clinical experience in such settings as ENT, hospital, and multi-specialty clinics where she worked with a variety of age populations and focused on diagnostics, hearing aid services, vestibular care, and electrophysiological testing. She obtained her B.S. from the University of Arizona, M.S. from Arizona State University and AuD from A.T. Still University. She is currently a member of the American Speech Hearing Association and American Academy of Audiology and holds her Clinical Certificate of Competency in Audiology

Facilitated by:

Jeanette Fitzke, AuD, CCC-A

Field Clinical Audiologist/Team Lead (Western US & Canada)

Otometrics (Division of Natus)

Jason Faloon

District Sales Manager: CO, AZ, NM, S. NV, El Paso

Otometrics (Division of Natus)

About Otometrics:
Otometrics, a division of Natus, is the audiology industry leader. For more than 50 years, Otometrics has been helping hearing and balance care professionals improve the quality of life for their clients and patients by delivering expert knowledge, reliable solutions and services and trusted partnership.

Otometrics develops, manufactures and markets audiological, otoneurologic and vestibular instrumentation in more than 80 countries under the Otometrics brands, including Madsen®, Aurical®, ICS®, Oscilla®, Otoscan® and Bio-logic®. Otometrics is a strategic business unit of Natus Medical Incorporated (North America NASDAQ: BABY) — a US-based leading provider of healthcare products, devices and services used in the newborn, neurology, sleep, hearing and balance markets. For more information, please visit www.otometrics.com or www.natus.com.

More courses available at: www.otometrics.us/education